AI VIVO is a Cambridge (UK) based company with a unique systems pharmacology platform powered by AI to accelerate drug discovery. We believe biology, health and disease are all about balance and imbalance. Our platform provide a proprietary system-driven methodology to represent these imbalances using functional omics data and predict unexpected novel modulation strategies to restore the stability and alleviating pathological imbalance. This disruptive technology enables us to speed up the whole drug discovery process by identify promising candidates, de-risk the opportunities through preclinical validations, and progress drug candidates to the clinic through industry and investor partnerships.